Yüklüyor......
Non‐Vitamin K Antagonist Oral Anticoagulants Provide Less Adverse Renal Outcomes Than Warfarin In Non‐Valvular Atrial Fibrillation: A Systematic Review and MetaAnalysis
BACKGROUND: Non‐vitamin K antagonist oral anticoagulants (NOACs) have better pharmacologic properties than warfarin and are recommended in preference to warfarin in most patients with non‐valvular atrial fibrillation. Besides lower bleeding complications, other advantages of NOACs over warfarin part...
Kaydedildi:
| Yayımlandı: | J Am Heart Assoc |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8174352/ https://ncbi.nlm.nih.gov/pubmed/33728927 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.120.019609 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|